To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Lee Equity clinches multi-part urology deal, distress anticipated in other PPM specialties; GA rides Royalty Pharma growth
Lee Equity Partners acquired and merges two urological-care providers and Royalty Pharma has the largest IPO of this year so far.
